News Foley Represents Bioluminescence Ventures in Emergence from Stealth with $477M AUM Foley & Lardner LLP represented Bioluminescence Ventures in its emergence from stealth with $477M in…Louis LehotNovember 1, 2023
Blogs Strengthening the Flow of the Biotech Sector’s M&A Pipeline Originally published in Genetic Engineering News on October 10, 2023. Reprinted with permission. The biotechnology sector has long…Louis LehotOctober 23, 2023
Blogs California Expands Data Deletion Rights Against Data Brokers On October 10, 2023, California Governor Gavin Newsom signed into law SB-362, a measure amending existing…Jennifer HennessyOctober 16, 2023
Events Founders & Funders October 24, 2023 | San Francisco, CA Foley & Lardner is proud to host the…Louis LehotOctober 12, 2023
Events 11th Annual BayBrazil Conference; Brazil in the 21st Century October 27, 2023 | Menlo Park, CA Foley & Lardner Partner André Thiollier will moderate…Andre ThiollierOctober 12, 2023
Blogs Navigating the AI Frontier: Legal and Operational Insights Into Generative AI In our ever-changing technological environment, artificial intelligence (AI) is beginning to exert its influence on…Natasha AllenOctober 11, 2023
News Louis Lehot and Eric Chow Author Article on Biotech Sector’s M&A Pipeline Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the GEN article, “Strengthening the Flow…Louis LehotOctober 10, 2023
Events Private Equity San Francisco Forum Foley proudly sponsored the annual Private Equity San Francisco Forum, which has been developed as…Louis LehotOctober 4, 2023
Blogs The Importance of ESG for Startups: Pioneering a Sustainable Future Partners Louis Lehot and Michael Kirwan published an article in Reuters Legal News titled: “The Importance of…Louis LehotSeptember 29, 2023
News Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million…Louis LehotSeptember 27, 2023